Punjab Develops New Vaccine to Prevent Breast Cancer
LAHORE – The Institute of Public Health Punjab has announced the development of a vaccine aimed at preventing breast cancer in women, marking a significant milestone for the country’s healthcare sector.
A policy dialogue is underway regarding the production of the Human Papillomavirus (HPV) vaccine, which experts believe could have a major impact on women’s health nationwide.
Punjab Finance Minister Mujtaba Shuja praised the development, saying the provincial government is prioritizing the health sector. He called the creation of the Papilloma Vaccine by the Institute of Public Health a “remarkable achievement.”
Medical expert Professor Dr. Javed Akram said the vaccine could play a key role in breast cancer prevention. He explained that administering three doses to girls at the age of 12 could provide lifelong protection against the disease.
US Approves New Breast Cancer Drug
In related news, the U.S. Food and Drug Administration (FDA) recently approved Datroway, a precision breast cancer drug developed by AstraZeneca in partnership with Japanese company Daiichi Sankyo. The treatment is intended for patients with advanced breast cancer who have already undergone prior therapies.
Priced at $4,891.07 per vial, Datroway will be available in the U.S. by prescription within the next two weeks. The drug belongs to a class of medicines called antibody-drug conjugates (ADCs), often referred to as “guided missiles” because they target cancer cells specifically, leaving healthy cells largely unharmed, unlike traditional chemotherapy.
Mutib Khalid is a skilled content writer and digital marketer with a knack for crafting compelling narratives and optimizing digital strategies. Excel in creating engaging content that drives results and enhances online presence. Passionate about blending creativity with data-driven approaches, Mutib Khalid helps brands connect with their audience and achieve their goals.